Jacobi Med. Ctr. Bronx NICHD CRS

The Bronx, New York 10461

0 studies enrolling now · 23 studies all time

What they study most

H1N1 Influenza Virus, HIV Infections, HIV Seronegativity, HIV Wasting Syndrome, Influenza, Lipodystrophy, Meningitis, Respiratory Syncytial Virus (RSV), Respiratory Syncytial Virus Infections, Sexually Transmitted Diseases, Tuberculosis

Studies at this site

• The LATITUDE Study: Long-Acting Therapy to Improve Treatment SUccess in Daily LifE — Running, not enrolling
• Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy — Completed
• Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and Postpartum — Completed
• Safety and Immunogenicity of a Single Dose of the Recombinant Live-Attenuated Respiratory Syncytial Virus (RSV) Vaccines RSV ΔNS2/Δ1313/I1314L, RSV 6120/ΔNS2/1030s, RSV 276 or Placebo, Delivered as Nose Drops to RSV-Seronegative Children 6 to 24 Months of Age — Stopped early
• Evaluating the Safety and Pharmacokinetics of VRC01, VRC01LS, and VRC07-523LS, Potent Anti-HIV Neutralizing Monoclonal Antibodies, in HIV-1-Exposed Infants — Completed
• Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age — Completed
• Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age — Completed
• Blood Levels of Anti-HIV Drugs Used in Combination Regimens in HIV Infected Children — Completed
• Evaluating the Safety and Pharmacokinetics of Raltegravir in Infants — Completed
• Safety and Immune Response to Vicriviroc in Combination Regimens in HIV-Infected ART Experienced Children and Adolescents — Completed
• Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and Adolescents — Completed
• Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children — Completed
• Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children — Completed
• Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women — Completed
• Safety of and Immune Response to an H1N1 Influenza Virus Vaccine in HIV Infected Children and Youth — Completed
• Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth — Completed
• Evaluating the Safety and Tolerability of Etravirine in HIV-1 Infected Infants and Children — Completed
• Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents — Completed
• Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents — Completed
• Growth Hormone Treatment of Children With HIV-Associated Growth Failure — Completed
• A Study of the Effects of Giving Two Anti-HIV Vaccines to Babies of HIV-Positive Mothers — Completed
• Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age — Completed
• The Effect of Anti-HIV Treatment on Body Characteristics of HIV-Infected Children — Completed